Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Anti-malarial efficacy of pyronaridine and artesunate in combination in vitro and in vivo

Vivas, Livia, Rattray, Lauren, Stewart, Lindsay, Bongard, Emily ORCID: https://orcid.org/0000-0001-5957-6280, Robinson, Brian L., Peters, Wallacf and Croft, Simon L. 2008. Anti-malarial efficacy of pyronaridine and artesunate in combination in vitro and in vivo. Acta Tropica 105 (3) , pp. 222-228. 10.1016/j.actatropica.2007.12.005

Full text not available from this repository.

Abstract

Pyronaridine is a Mannich base anti-malarial with demonstrated efficacy against drug resistant Plasmodium falciparum, P. vivax, P. ovale and P. malariae. However, resistance to pyronaridine can develop quickly when it is used alone but can be considerably delayed when it is administered with artesunate in rodent malaria models. The aim of this study was to evaluate the efficacy of pyronaridine in combination with artesunate against P. falciparum in vitro and in rodent malaria models in vivo to support its clinical application. Pyronaridine showed consistently high levels of in vitro activity against a panel of six P. falciparum drug-sensitive and resistant strains (Geometric Mean IC50 = 2.24 nM, 95% CI = 1.20–3.27). In vitro interactions between pyronaridine and artesunate showed a slight antagonistic trend, but in vivo compared to pyronaridine and artesunate administered alone, the 3:1 ratio of the combination, reduced the ED90 of artesunate by ∼15.6-fold in a pyronaridine-resistant P. berghei line and by ∼200-fold in an artesunate-resistant line of P. berghei. Complete cure rates were achieved with doses of the combination above or equal to 8 mg/kg per day against P. chabaudi AS. These results indicate that the combination had an enhanced effect over monotherapy and lower daily doses of artesunate could be used to obtain a curative effect. The data suggest that the combination of pyronaridine and artesunate should have potential in areas of multi-drug resistant malaria.

Item Type: Article
Date Type: Publication
Status: Published
Schools: Medicine
Subjects: R Medicine > RB Pathology
R Medicine > RM Therapeutics. Pharmacology
Uncontrolled Keywords: pyronaridine, artesunate, malaria, plasmodium falciparum, drug combinations
Publisher: Elsevier
ISSN: 0001-706X
Last Modified: 19 Oct 2022 10:13
URI: https://orca.cardiff.ac.uk/id/eprint/23635

Citation Data

Cited 49 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item Edit Item